This study is in progress, not accepting new patients

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

a study on Cirrhosis Primary Biliary Cholangitis

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UC Davis
Dates
study started
completion around

Description

Summary

This is a 5-year, longitudinal, observational study of patients with PBC designed to specifically address important clinical questions that remain incompletely answered from registration trials. In addition to the study database, a bio specimen repository will also be included so that translational studies of genomics and biomarkers of response may be performed.

Keywords

Biliary Cirrhosis, Primary, Cholangitis, Biliary Liver Cirrhosis

Eligibility

You can join if…

Open to people ages 18 years and up

- Adult patients (age 18 or older) being treated or managed for PBC

You CAN'T join if...

  • Inability to provide written informed consent
  • Simultaneous enrollment in another prospective registry or clinical trial or study where PBC treatment outcomes are reported, except where approved or conducted as an adjunct project of TARGET-PBC

Locations

  • University of California Davis
    Sacramento California 95817 United States
  • California Liver Research Institute
    Pasadena California 91105 United States
  • Stanford University Medical Center
    Palo Alto California 94304 United States

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Target PharmaSolutions, Inc.
ID
NCT02932449
Study Type
Observational
Participants
Expecting 1500 study participants
Last Updated